PRIORIX-TETRA
PRIORIX-TETRA
Approved
DIN Number
02297884
Drug Class
Human
Market Date
Jun 4, 2008
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02297884
AIG Number0464901001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BD54 MEASLES, COMBINATIONS WITH MUMPS, RUBELLA AND VARICELLA, LIVE ATTENUATED
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular
,
Subcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
MEASLES VIRUS VACCINE LIVE ATTENUATEDActive
Strength: 1000 CCID50 / 0.5 ML
Monograph: MEASLES VIRUS VACCINE LIVE ATTENUATED
MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN)Active
Strength: 25118.9 CCID50 / 0.5 ML
Monograph: MUMPS VIRUS VACCINE LIVE ATTENUATED (JERYL LYNN STRAIN)
RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)Active
Strength: 1000 CCID50 / 0.5 ML
Monograph: RUBELLA VIRUS VACCINE LIVE ATTENUATED (WISTAR RA27/3 STRAIN)
VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN)Active
Strength: 1995.2623 CCID50 / 0.5 ML
Monograph: VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED (OKA-STRAIN)